sulfacetamide sodium 100 MG/ML Ophthalmic Solution

What the CMS Formulary Data Shows for sulfacetamide sodium 100 MG/ML Ophthalmic Solution

Per the CMS 2026 Part D formulary file, sulfacetamide sodium 100 MG/ML Ophthalmic Solution (RxNorm concept RXCUI 1006120, generic name sulfacetamide sodium) appears on 330 distinct formulary files spanning 5,067 Medicare Part D plan offerings - 100% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.

Real-world access to sulfacetamide sodium 100 MG/ML Ophthalmic Solution depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 11.2% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 23,854 Part D beneficiaries filled sulfacetamide sodium 100 MG/ML Ophthalmic Solution in 2023, with total plan-and-beneficiary spending of $2,124,262 and an average per-beneficiary annual cost of $89.05. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry sulfacetamide sodium 100 MG/ML Ophthalmic Solution today.